Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications. | Int J Mol Sci | 2021 | 34206399 | PubTator, text mining | PubMed |
| Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2021 | 34205588 | PubTator, text mining | PubMed |
| Challenges with Approved Targeted Therapies against Recurrent Mutations in CLL: A Place for New Actionable Targets. | Cancers (Basel) | 2021 | 34202439 | PubTator, text mining | PubMed |
| Discovery of Antivirals Using Phage Display. | Viruses | 2021 | 34200959 | PubTator, text mining | PubMed |
| Will New Drugs Replace Transplants for Chronic Lymphocytic Leukaemia? | J Clin Med | 2021 | 34200119 | PubTator, text mining | PubMed |
| Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients. | Cancers (Basel) | 2021 | 34198760 | PubTator, text mining | PubMed |
| The protein landscape of chronic lymphocytic leukemia. | Blood | 2021 | 34189564 | PubTator, text mining | PubMed |
| Multivariate transcriptome analysis identifies networks and key drivers of chronic lymphocytic leukemia relapse risk and patient survival. | BMC Med Genomics | 2021 | 34187466 | PubTator, text mining | PubMed |
| SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. | Nature | 2021 | 34182569 | PubTator, text mining | PubMed |
| Time-limited, Combined Regimen in Chronic Lymphocytic Leukemia: A Promising Strategy to Achieve a Drug Holiday. | Curr Med Sci | 2021 | 34181208 | PubTator, text mining | PubMed |
| Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway. | Front Immunol | 2021 | 34177947 | PubTator, text mining | PubMed |
| The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia. | Hematol Oncol Clin North Am | 2021 | 34174987 | PubTator, text mining | PubMed |
| First-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both? | Hematol Oncol Clin North Am | 2021 | 34174983 | PubTator, text mining | PubMed |
| The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model. | Clin Cancer Res | 2021 | 34168050 | PubTator, text mining | PubMed |
New kid on the block: C-reactive protein-to-albumin ratio as a new prognostic marker for chronic lymphocytic leukemia: Comment on "C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases". | Transl Oncol | 2021 | 34167746 | PubTator, text mining | PubMed |
| Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. | Nature | 2021 | 34126625 | PubTator, text mining | PubMed |
| NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status. | Front Oncol | 2021 | 34123837 | PubTator, text mining | PubMed |
| A Review of the Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies. | J Adv Pract Oncol | 2021 | 34123480 | PubTator, text mining | PubMed |
| Prospects of Neutralizing Nanobodies Against SARS-CoV-2. | Front Immunol | 2021 | 34122456 | PubTator, text mining | PubMed |
| The Diagnostic and Prognostic Potential of the B-Cell Repertoire in Membranous Nephropathy. | Front Immunol | 2021 | 34122405 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=44